pubmed-article:1850149 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1850149 | lifeskim:mentions | umls-concept:C0699885 | lld:lifeskim |
pubmed-article:1850149 | lifeskim:mentions | umls-concept:C0004927 | lld:lifeskim |
pubmed-article:1850149 | lifeskim:mentions | umls-concept:C0016911 | lld:lifeskim |
pubmed-article:1850149 | lifeskim:mentions | umls-concept:C0027646 | lld:lifeskim |
pubmed-article:1850149 | lifeskim:mentions | umls-concept:C0178759 | lld:lifeskim |
pubmed-article:1850149 | lifeskim:mentions | umls-concept:C1979874 | lld:lifeskim |
pubmed-article:1850149 | lifeskim:mentions | umls-concept:C0024943 | lld:lifeskim |
pubmed-article:1850149 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:1850149 | pubmed:dateCreated | 1991-5-23 | lld:pubmed |
pubmed-article:1850149 | pubmed:abstractText | 33 patients with tumours of the urinary bladder were studied via MR, both with and without the paramagnetic contrast medium Gd-DTPA. Results were compared with the final pathological classification after TUER and bimanual palpation. The signal intensity ratio of tumour tissue/fat and tumour/muscle were calculated on T1 weighted images and after GD-DTPA and examined for their statistical significance. The increase in signal intensity of the tumours was statistically significant (Wilcoxon test p less than 0.01). There was no advantage for the T2 weighted images compared with Gd-contrasted enhanced T1 weighted images. MRI staging was correct in 28 out of 33 cases (accuracy 84.8%). Because of the relatively short acquisition time of T1 weighted images and the specific tumour enhancement, administration of Gd-DTPA proved to be of help in the staging of the carcinoma of the bladder. Two small tumours and regressive changes in central areas of tumours were recognised after Gd-DTPA. | lld:pubmed |
pubmed-article:1850149 | pubmed:language | ger | lld:pubmed |
pubmed-article:1850149 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1850149 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1850149 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1850149 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1850149 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1850149 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1850149 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1850149 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1850149 | pubmed:month | Apr | lld:pubmed |
pubmed-article:1850149 | pubmed:issn | 1438-9029 | lld:pubmed |
pubmed-article:1850149 | pubmed:author | pubmed-author:SchmollerHH | lld:pubmed |
pubmed-article:1850149 | pubmed:author | pubmed-author:JoosHH | lld:pubmed |
pubmed-article:1850149 | pubmed:author | pubmed-author:DoringerEE | lld:pubmed |
pubmed-article:1850149 | pubmed:author | pubmed-author:ForstnerRR | lld:pubmed |
pubmed-article:1850149 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1850149 | pubmed:volume | 154 | lld:pubmed |
pubmed-article:1850149 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1850149 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1850149 | pubmed:pagination | 357-63 | lld:pubmed |
pubmed-article:1850149 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:meshHeading | pubmed-meshheading:1850149-... | lld:pubmed |
pubmed-article:1850149 | pubmed:year | 1991 | lld:pubmed |
pubmed-article:1850149 | pubmed:articleTitle | [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior]. | lld:pubmed |
pubmed-article:1850149 | pubmed:affiliation | Röntgendiagnostisches Zentralinstitut der Landeskrankenanstalten, Salzburg. | lld:pubmed |
pubmed-article:1850149 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1850149 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:1850149 | pubmed:publicationType | English Abstract | lld:pubmed |